Vertex Pharmaceuticals Total Long Term Liabilities 2010-2024 | VRTX

Vertex Pharmaceuticals total long term liabilities for the quarter ending September 30, 2024 were $2.636B, a 63.33% increase year-over-year.

  • Vertex Pharmaceuticals total long term liabilities for 2023 were $1.602B, a 7.11% increase from 2022.
  • Vertex Pharmaceuticals total long term liabilities for 2022 were $1.496B, a 25.67% increase from 2021.
  • Vertex Pharmaceuticals total long term liabilities for 2021 were $1.191B, a 0.25% increase from 2020.

Vertex Pharmaceuticals Total Long Term Liabilities 2010-2024 | VRTX

  • Vertex Pharmaceuticals total long term liabilities for 2023 were $1.602B, a 7.11% increase from 2022.
  • Vertex Pharmaceuticals total long term liabilities for 2022 were $1.496B, a 25.67% increase from 2021.
  • Vertex Pharmaceuticals total long term liabilities for 2021 were $1.191B, a 0.25% increase from 2020.